Indoco Remedies has informed that USFDA inspected the Company’s Goa Plant II from August 31, 2016 to September 04, 2016. The injectable ANDA filings triggered this inspection. At the end of the inspection, six 483s were issued. All the observations (483s) are correctable and the Company expects to complete the corrective and preventive actions within a period of 30 days. None of the 483s are related to Data Integrity issue.
The above information is a part of company’s filings submitted to BSE.